重组抗人HLA Class I Heavy Chain单抗(HC10) | Syd Labs PA007479.m2a

重组抗人HLA Class I Heavy Chain单抗(HC10) Syd Labs PA007479.m2a - 武汉多找找科技

重组抗人HLA Class I Heavy Chain单抗(HC10) | Syd Labs PA007479.m2a

In stock

一键复制

体内实验级重组抗人HLA Class I Heavy Chain单克隆抗体,小鼠IgG2a Kappa(克隆号HC10,Syd Labs货号:PA007479.m2a),适用于体外和体内研究,纯度>95%。其不变区为小鼠Mouse IgG2a Kappa (mIgG2a或m2a),可与重组小鼠IgG2a同型对照抗体配套使用。样品制备条件和最佳样品稀释度应由研究人员通过实验确定。

产品参数

货号 PA007479.m2a
产品名称重组抗人HLA Class I Heavy Chain单抗(HC10) | Syd Labs PA007479.m2a
英文名 In vivo Grade Recombinant Anti-Human HLA Class I Heavy Chain Monoclonal Antibody, Mouse IgG2a Kappa (Clone: HC10)
供货商名称 Syd Labs, Inc.
品牌名 Syd Labs
别称 Major Histocompatibility Class I, MHC class I, human leukocyte antigen (HLA), HLA class I histocompatibility antigen
概述 Syd Labs提供重组小鼠IgG2a同型对照抗体。样品制备条件和最佳样品稀释度应由研究人员通过实验确定。
克隆号 HC10
同种型 小鼠 IgG2a kappa
应用 ELISA、流式细胞术、中和、功能测定,如生物分析PK和ADA测定,以及用于研究受人HLA Class I Heavy Chain蛋白影响的生物途径的测定。
免疫源 抗人HLA Class I Heavy Chain单克隆抗体(克隆:HC10)在哺乳动物细胞中产生
抗体形式 0.2 μM过滤溶液,1x PBS
内毒素 根据 LAL 方法,≤1 EU每1mg 蛋白质
纯度 >95%(在还原条件下通过SDS-PAGE测定)
运输 体内实验级重组抗人HLA Class I Heavy Chain单克隆抗体 ,小鼠IgG2a Kappa(克隆号HC10)用冰袋运输。收到后,请立即将其存放在下面建议的温度下。
稳定性与存储 使用手动除霜冰箱并避免重复冻融循环。 自收到之日起 1 个月,保存在2 至 8°C。 自收到之日起12个月,保存在-20 至 -70°C。
注意事项 PA007479.m2a Syd Labs提供重组小鼠IgG2a同型对照抗体。样品制备条件和最佳样品稀释度应由研究人员通过实验确定。
产品咨询 Syd Labs在国内只通过代理商销售其产品,不做直销。终端用户咨询价格请联系Syd Labs中国代理商。
关于Syd Labs产品如果有任何技术或其它问题,欢迎随时联系Syd Labs国内市场推广合作伙伴:武汉多找找科技有限公司,企业微信:duozhaozhao2024 联系电话:18162581039(龙经理)
应用详情 ELISA、流式细胞术、中和、功能测定,如生物分析PK和ADA测定,以及用于研究受人HLA Class I Heavy Chain蛋白影响的生物途径的测定。

文献

抗人HLA Class I Heavy Chain单克隆抗体,体内实验级重组,小鼠IgG2a Kappa(克隆号HC10)(In vivo Grade Recombinant Anti-Human HLA Class I Heavy Chain Monoclonal Antibody, Mouse IgG2a Kappa (Clone: HC10),货号:PA007479.m2a Syd Labs)

人类主要组织相容性复合体(MHC)在提呈抗原及调控免疫应答中发挥关键作用,其中 HLA I 类与 II 类分子共同构成了抗原递呈系统的核心。在各类抗原提呈细胞(APC)与活化 T 细胞表面,HLA II 类分子(包括 HLA-DR、HLA-DP 和 HLA-DQ)负责将外源性肽段提呈给 CD4+ T 细胞,是启动体液与细胞免疫的核心靶点。免疫学研究中,广谱识别能力强且特异性高的抗人HLA-DR/DP/DQ单抗(如经典的 F3.3抗体 克隆)是解析 MHC-II 途径功能的重要分子工具。此类抗体不仅能有效阻断或阻断介导的免疫激活,还在肿瘤免疫检查点探索、器官移植排斥反应机制研究及自身免疫性疾病发病机理分析等领域扮演着不可或缺的角色。

为满足前沿科研与高标准实验的要求,Syd Labs 与同类品牌(如 BioXCell 等)共同为全球科研机构提供高规格的体内实验级重组抗体产品。Syd Labs 提供的重组抗人HLA-DR/DP/DQ单抗(如 F3.3抗体 等规格)基于严谨的哺乳动物细胞重组表达平台精制而成,具有极高的靶向特异性与卓越的批间稳定性。产品专为敏感的体内(in vivo)动物模型阻断与体外功能分析深度优化,严格把控低内毒素水平(Low Endotoxin),且无载体蛋白及化学防腐剂干扰,可无缝配合小鼠 IgG2a 同型对照抗体使用,为移植免疫、免疫微环境研究及抗体药物开发提供科学严谨、高度可重复的实验数据保障。

抗人HLA Class I Heavy Chain单抗(HC10)部分引用文献:

1. Gemcitabine Modulates HLA-I Regulation to Improve Tumor Antigen Presentation by Pancreatic Cancer Cells
Larson, A.C., et al. Int J Mol Sci. 2024; 25(6):3211. PMID: 38537988
“The HC10 antibody (anti-human HLA Class I Heavy Chain) was used to detect HLA-B and HLA-C heavy chains in western blot and flow cytometry analyses of pancreatic cancer cell lines (S2-013, PANC-1). …Gemcitabine treatment strongly increased HLA-B/C protein expression and surface levels, with similar amplification to HLA-A2, enhancing tumor antigen presentation despite a milder effect on HLA-A.”

2. Endo-lysosomal assembly variations among human leukocyte antigen class I allotypes
Olson, E., et al. eLife. 2023; 12:e79144. PMID: 36722462
“The HC10 antibody (anti-human HLA Class I Heavy Chain) detected peptide-deficient HLA-B and HLA-C heavy chain conformations in bead-based assays, showing reduced signals with high-affinity peptide loading for B08:01 and B35:01 allotypes. …Flow cytometry revealed that HC10 signals did not increase with beta2m loss, indicating internalization of heterodimeric HLA class I complexes in moDCs.”

3. Antibody-mediated delivery of viral epitopes to tumors harnesses CMV-specific T cells for cancer therapy
Millar, D.G., et al. Nat Biotechnol. 2020; 38:420-425. PMID: 32015550
“The HC10 antibody (anti-human HLA Class I Heavy Chain) was used to assess empty HLA molecules on Colo205 tumor cells via flow cytometry. …After acid-stripping peptides from surface MHC molecules, HC10 staining showed a decrease in empty MHC molecules, supporting the use of antibody-peptide epitope conjugates (APECs) to retarget CMV-specific CD8+ T cells for tumor therapy.”

4. In vivo Downregulation of MHC Class I Molecules by HCMV Occurs During All Phases of Viral Replication but Is Not Always Complete
Gabor, F., et al. Front Cell Infect Microbiol. 2020; 10:283. PMID: 32596168
“The HC10 antibody (anti-human HLA Class I Heavy Chain), provided by Dr. H. L. Ploegh, detected HLA-B, HLA-C, and select HLA-A heavy chains (e.g., HLA-A10, A28-A33) in HCMV-infected cells via flow cytometry. …It revealed strong but incomplete MHC class I downregulation, with some cells showing weak to normal HC10 signals compared to uninfected cells.”

5. The amino acid at position 97 is involved in folding and surface expression of HLA-B27
Blanco-Gelaz, M.A., et al. Int Immunol. 2006; 18(1):211-20. PMID: 16361312
“The HC10 antibody (anti-human HLA Class I Heavy Chain), provided by Dr. Ted Hansen and Dr. H. L. Ploegh, was used to detect beta2m-free HLA-B and HLA-C heavy chains, including select HLA-A isoforms (e.g., HLA-A10, A28-A33). …Flow cytometry confirmed that beta2m-free heavy chains originate from surface beta2m-associated MHC class I molecules, with position 97 affecting HLA-B27 folding and expression.”